Rigel Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Rigel Pharmaceuticals's balance sheet done over the years? Its assets were worth $117,225,000 last year, which is less than in the previous period. 124% of Rigel Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $145,869,000, which means an decrease by -1% compared compared to last year.
Debt to Assets
| 2014 | 154135000 | 25.88M | 16.8% |
|---|---|---|---|
| 2015 | 131747000 | 40.36M | 30.64% |
| 2016 | 78134000 | 23.10M | 29.57% |
| 2017 | 119111000 | 18.46M | 15.5% |
| 2018 | 139109000 | 29.23M | 21.01% |
| 2019 | 147569000 | 93.75M | 63.53% |
| 2020 | 110378000 | 76.35M | 69.17% |
| 2021 | 167328000 | 136.95M | 81.85% |
| 2022 | 134279000 | 147.89M | 110.14% |
| 2023 | 117225000 | 145.86M | 124.44% |
RIGL Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 32.78M | 24.45M | 18.89M | 30.37M | 22.52M | 76.32M | 38.29M | 17.63M | 43.45M | 15.20M |
Short term investments | 24.14M | 33.74M | 106.07M | 26.95M | 75.55M | 52.21M | 77.46M | 57.13M | 82.82M | 127.95M |
Net receivables | 30.55M | 40.32M | 15.47M | 15.97M | 10.11M | 4.07M | 0 | 0 | 203K | 5.75M |
Inventory | 5.52M | 9.11M | 6.61M | 1.63M | 1.35M | 894K | 0 | 0 | 0 | 0 |
Other current assets | 6.26M | 8.25M | 7.41M | 14.04M | 9.46M | 3.47M | 3.36M | 1.44M | 5.09M | 3.25M |
Total current assets | 99.26M | 115.90M | 154.46M | 88.98M | 119.00M | 136.98M | 117.43M | 76.21M | 129.02M | 150.53M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 1.02M | 2.78M | 11.88M | 20.57M | 27.86M | 1.38M | 875K | 1.15M | 1.61M | 2.50M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 13.87M | 14.94M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 3.05M | 640K | 974K | 824K | 696K | 735K | 803K | 764K | 1.11M | 1.08M |
Total non-current assets | 17.95M | 18.37M | 12.86M | 21.39M | 28.56M | 2.12M | 1.67M | 1.92M | 2.72M | 3.59M |
Total assets | 117.22M | 134.27M | 167.32M | 110.37M | 147.56M | 139.10M | 119.11M | 78.13M | 131.74M | 154.13M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 1.35M | 13.51M | 2.59M | 3.01M | 25.28M | 1.03M | -284K | -3.22M | 13.42M | -2.80M |
Short term debt | 8.61M | 1.13M | 9.89M | 8.62M | 7.27M | 0 | 0 | 3.22M | 0 | 0 |
Total current liabilities | 53.26M | 65.21M | 63.55M | 40.84M | 58.21M | 27.73M | 18.33M | 22.58M | 33.79M | 14.02M |
| Non-current liabilities: | ||||||||||
Long term debt | 52.65M | 40.42M | 20.67M | 30.46M | 29.04M | 0 | 0 | 238K | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 39.94M | 42.26M | 52.72M | 5.04M | 5.09M | 90K | 128K | 281K | 6.57M | 11.86M |
Total non-current liabilities | 92.60M | 82.68M | 73.4M | 35.51M | 35.54M | 1.49M | 128K | 519K | 6.57M | 11.86M |
Total liabilities | 145.86M | 147.89M | 136.95M | 76.35M | 93.75M | 29.23M | 18.46M | 23.10M | 40.36M | 25.88M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |